Clinical Trial Update: Efficacy and Tolerability of Escitalopram and Duloxetine in Outpatients With Major Depressive Disorder [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating the efficacy and tolerability of escitalopram and duloxetine in outpatients with major depressive disorder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Duloxetine (DULOXETINE)
• Escitalopram (escitalopram)

Snippet

Sponsor: H. Lundbeck A/S | Conditions: Major Depressive Disorder | Phase 4 | Status: COMPLETED